Risks and Incidents Involving Simulated Medications
Schroeder, J., O’Neal, C., & Jagneaux, T. (2015). Practically Saline. Journal of investigative medicine high impact case reports, 3(4), 2324709615618980. doi:10.1177/2324709615618980
Torrie J, Cumin D, Sheridan J, Merry AF. Fake and expired medications in simulation-based education: An underappreciated risk to patient safety. BMJ Quality and Safety 2016;25(12):917-20. doi: 10.1136/bmjqs-2015-004793
Strategies and Policy Development
Bajaj K, Minors A, Walker K, Meguerdichian M, Patterson M. “No-Go Considerations” for In Situ Simulation Safety. Simul Healthc. 2018 Apr 4.
Brazil, V., Scott, C., Matulich, J. et al. Developing a simulation safety policy for translational simulation programs in healthcare. Adv Simul 7, 4 (2022).
Brazil V, Purdy E. Simulation Safety Spotlight – a call for Safety briefings in sim. International Clinical Educators Network Royal College of Physicians and Surgeons of Canada. 2019. Accessed February 27, 2022.
Simulation Safety Editorial
Simulation Safety First: An Imperative
Raemer, D, Hannenberg, A, Mullen, A. Simulation Safety First; An Imperative. Simul Healthc. 2018 Dec.
Raemer DB. Ignaz Semmelweis Redux? Simul Healthc. 2014 Jun;9(3):153-5. PMID 24401925
Simulation Safety Editorial : Portuguese Translation
Simulation Safety First Editorial; Translated by Henrique Pierotti Arantes, MD and Carolina Alexio.
Simulation Safety Editorial : Spanish Translation
Primero la Seguridad en la Simulación* Un imperativ
Simulation Safety First Editorial; Translated by Priscilla Carmiol-Rodríguez, Revisions by Demian Szyld and Jose M. Maestre
Foundation for Healthcare Simulation Safety 